Curis (CRIS) Capital Expenditures Growth (1y) (2011 - 2020)
Curis (CRIS) Capital Expenditures Growth (1y) (2011 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2020 |
285.37% |
| Sep 30, 2019 |
-46.75% |
| Sep 30, 2018 |
266.67% |
| Jun 30, 2018 |
-193.24% |
| Mar 31, 2018 |
48.08% |
| Dec 31, 2017 |
-31.67% |
| Sep 30, 2017 |
61.54% |
| Jun 30, 2017 |
-70.16% |
| Mar 31, 2017 |
550.00% |
| Sep 30, 2016 |
-60.61% |
| Jun 30, 2016 |
576,644.19% |
| Mar 31, 2016 |
-46.51% |
| Sep 30, 2015 |
378.05% |
| Dec 31, 2014 |
41.42% |
| Sep 30, 2014 |
-93.06% |
| Dec 31, 2013 |
-70.46% |
| Sep 30, 2013 |
1,068.66% |
| Mar 31, 2013 |
232.67% |
| Dec 31, 2012 |
476.02% |
| Sep 30, 2012 |
172.62% |
